Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;39(11):e70008.
doi: 10.1002/bio.70008.

Spectrofluorometric Turn-Off Sensing Probe for Tolmetin Determination Using Cerium and Nitrogen Codoped Carbon Dots

Affiliations

Spectrofluorometric Turn-Off Sensing Probe for Tolmetin Determination Using Cerium and Nitrogen Codoped Carbon Dots

Mokhtar M Mabrouk et al. Luminescence. 2024 Nov.

Abstract

A facile, low-cost, and rapid method was developed for spectrofluorometric determination of tolmetin (TOL) using highly fluorescent (QY = 35%) cerium and nitrogen codoped carbon dots (Ce-NCDs) sensing platform prepared by one-step hydrothermal method. Owing to the severe overlap between TOL absorption and Ce-NCDs excitation spectra around 320 nm, TOL could attenuate the emission of Ce-NCDs at 407 nm through primary inner filter effect (IFE). This concentration dependent attenuation was linear between 2 and 10 μg/mL (r = 0.9993) with a limit of detection of 0.5 μg/mL. The sensor showed very good accuracy (% recovery = 98%-100%) and precision (%RSD < 2). The developed sensing strategy was successfully applied for TOL detection as an active pharmaceutical ingredient in pharmaceutical formulation and as a potential pollutant in environmental water samples, such as tap and river water, with acceptable recovery and considerable selectivity. Thus, the direct single-step spectrofluorometric determination of TOL was enabled without extensive processing or chemical derivatization.

Keywords: cerium doped carbon dot; inner filter effect; quenching; spectrofluorometry; tolmetin.

PubMed Disclaimer

References

    1. J. E. Levinson, J. Baum, E. Brewer, C. Fink, V. Hanson, and J. Schaller, “Comparison of Tolmetin Sodium and Aspirin in the Treatment of Juvenile Rheumatoid Arthritis,” The Journal of Pediatrics 91 (1977): 799–804, https://doi.org/10.1016/S0022‐3476(77)81045‐7.
    1. S. M. Katz, “Tolmetin,” Journal of the American Medical Association 246 (1981): 243, https://doi.org/10.1001/jama.1981.03320030035024.
    1. A. A. Ramadan, A. M. Elbakry, A. H. Esmaeil, and S. A. Khaleel, “Pharmaceutical and Pharmacokinetic Evaluation of Novel Rectal Mucoadhesive Hydrogels Containing Tolmetin Sodium,” Journal of Pharmaceutical Investigation 48 (2018): 673–683, https://doi.org/10.1007/s40005‐017‐0365‐1.
    1. M. Bakhriansyah, P. C. Souverein, M. W. F. van den Hoogen, A. de Boer, and O. H. Klungel, “Risk of Nephrotic Syndrome for Non‐steroidal Anti‐inflammatory Drug Users,” Clinical Journal of the American Society of Nephrology 14 (2019): 1355–1362, https://doi.org/10.2215/CJN.14331218.
    1. D. A. Feinfeld, L. Olesnicky, C. L. Pirani, and G. B. Appel, “Nephrotic Syndrome Associated With Use of the Nonsteroidal Anti‐inflammatory Drugs,” Nephron 37 (1984): 174–179, https://doi.org/10.1159/000183239.

MeSH terms

LinkOut - more resources